
Experimental Treatments Aim to Prevent Brain Damage in Babies
Advances in neuroscience are driving the development of therapies that could save thousands of the most vulnerable patients
Erika Check Hayden works for Nature magazine.
Advances in neuroscience are driving the development of therapies that could save thousands of the most vulnerable patients
Researchers worry about misinforming people about the risk of disease
Country's progress on public health and science prompts funding shift to more-troubled nations
In one case, a nine-month-old child died from Ebola virus infection after her seemingly healthy mother passed the virus to her in breast milk
The feat, which radically altered Escherichia coli’s DNA, may be a big step forward for synthetic biology
Economists, investors and medical insurers can’t figure out how to pay for cutting-edge drugs
Patients say the diagnostics company violated their rights to their own genetic data
Specialized proteins can protect monkeys against the virus for months
Protection against virus raises hopes of vaccine development for dengue and even Zika
An antibody from a man who survived infection from the 1995 outbreak shows potent effect against deadly virus
Drugmaker commits to stockpiling 300,000 doses and beginning approval process
Report concludes that not enough has changed nearly two years after the start of the catastrophic west Africa epidemic
Tech firm’s ambitious goals and abundant resources attract life scientists, most recently Harvard Medical School cardiologist Jessica Mega
Organizations seek to help patients reintegrate into society after recovering
Nature reports from the front line of the outbreak
A new experiment will study life span extension via an antiaging drug administered to domestic dogs
The virus that causes Ebola is well understood but puzzling issues remain on topics such as the disease's lethality and whether the virus can be stopped
The response to Ebola could be undermined as Louisiana officials ask that doctors and researchers recently returned from three west African nations not attend the American Society of Tropical Medicine and Hygiene meeting November 2 to 6...
Public health experts fear that one epidemic may fuel another in West Africa
A new drug is one of thousands of drug-like molecules that may be produced by our microbiome
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account